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HYPOPHOSPHATASIA IN TAIWAN:
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Hypophosphatasia is a rare inherited metabolic disease characterized by rickets with reduced plasma and
tissue alkaline phosphatase activity. It may be present in infancy, childhood, or adulthood. Various clinical
manifestations reflect different forms of alkaline phosphatase gene expression. In this report, we present
two cases of hypophosphatasia, one of the infantile and the other of the adult form. The infantile case
presented with failure to thrive, hypotonia, and radiologic rickets at 4 months old. The adult case had
repeated fractures and marked loss of bone density demonstrated by radiographs. Both cases showed
extremely low levels of alkaline phosphatase. To the best of our knowledge, they are the first reported
patients with hypophosphatasia from the Taiwanese population.
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Hypophosphatasia is a hereditary disorder marked by a
deficiency of alkaline phosphatase (ALP) activity in the
liver, bones, and kidneys, and is associated with defective
skeletal mineralization. It is caused by the loss-of-function
mutations in the tissue nonspecific ALP gene (TNSALP), the
gene encoding the isoenzyme TNSALP, which is located in
the chromosome region 1p36.1–1p34 [1]. The large variation
in clinical manifestations of the disease reflects the extent
of the loss of enzyme function and may be indicated by a
variety of symptoms and signs over a wide range of ages [2].
To the best of our knowledge, there are no previous
reports of hypophosphatasia in the Taiwanese population.
We describe two cases of hypophosphatasia, one of the
infantile form confirmed by hypercalcemia and radiologic
rickets, and the other of the adult form that presented with
a history of premature loss of teeth and repeated fractures.
We discuss the clinical variation of the disease and
the treatments adopted to control chronic bone deminer-
alization.
CASE PRESENTATIONS
Case 1
A baby was referred at the age of 4 months for hypotonia,
failure to thrive, and rickets. She was the second child born
to unrelated parents without any family history of bone
disease. She was born at full term with a birth weight of
2.45 kg. Poor feeding, vomiting, and hypotonia developed
gradually. On examination, her body weight was 4.23 kg
and body length was 54 cm, both below the 10th percentile.
In addition, her head girth was 39.5 cm (10–25th percentile).
Physical examination showed widening of the anterior
fontanel and generalized hypotonia. No blue sclera or short
limbs were noted. Pertinent laboratory values were: se-
rum calcium concentration, 2.9 mmol/L (normal, 2.05–2.55
mmol/L); phosphate, 1.52 mmol/L (normal, 0.74–1.52
mmol/L); intact parathyroid hormone, 1.14 pmol/L (nor-
mal, 1.1–5.3 pmol/L); ALP, 12 U/L (normal at 4 months,
50–260 U/L). Urinary measurements included a calcium/
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creatinine ratio of 2.7 (normal, < 0.8). Roentgenograms
showed poor mineralization of the long bones, most
noticeable in the proximal femur and proximal humerus
(Figures A and B). There was poor ossification of the
epiphysis of bilateral distal ulnar, radius, and femur and
proximal tibia. Cranial computed tomography (CT) showed
decreased mineralization of the skull (Figure C). Renal
ultrasonography revealed echogenic medullary pyramids
consistent with nephrocalcinosis (Figure D). The diagnosis
of hypophosphatasia was made and treatment with
calcitonin and trichlormethiazide was started.
The baby was re-admitted at 5 months of age with
pneumonia, fever, vomiting and respiratory distress. Se-
rum calcium concentration was 2.3 mmol/L, phosphate
was 1.13 mmol/L, and ALP was 26 U/L. She died 2 weeks
later due to respiratory failure.
Case 2
This patient was referred to our endocrine clinic at the age
of 27 years due to repeat fractures. No family history of
metabolic bone disease was noted. Her history included the
premature shedding of deciduous teeth at 3 years old and
she had visited our dental department at the age of 17 for
periodontitis, enamel hypoplasia, and malocclusion. She
suffered right tibiofibular fracture when she was 23 years
old and a left femoral fracture when she was 26 years old.
Roentgenograms showed marked loss of bone density over
the long bones. Bone mineral density (BMD) at the right
femoral neck measured by dual-energy X-ray absorp-
tiometry showed severe osteoporosis with a Z-score of
–4.12. Laboratory investigations revealed a serum calcium
concentration of 2.4 mmol/L, a phosphate concentration
of 1.36 mmol/L, an ALP level of 6 U/L (normal adult,
30–110 U/L), and a 25-hydroxyvitamin D concentration of
49.25 nmol/L (normal, 35–150 nmol/L). The adult form of
hypophosphatasia was diagnosed. No further fracture epi-
sodes were noted during the 3 years of follow-up at our
clinic. Serial BMD measurements showed no significant
improvement, despite the use of oral alendronate. Follow-
up serum ALP was 5 U/L.
DISCUSSION
Hypophosphatasia was first described by Rathbun in 1948
[3], and since then, about 300 patients have been described
throughout the world [4]. Six forms of hypophosphatasia
have been identified [4]. The perinatal form is often lethal,
owing to deformation of the chest wall and respiratory
insufficiency, fractured extremities, and intracranial
hemorrhage [5]. Infantile hypophosphatasia manifests
before 6 months of age and patients appear normal until the
onset of failure to thrive and rickets. The cranial sutures are
wide, reflecting hypomineralization of the skull. A flail
chest from rachitic deformity predisposes the infant to re-
current pneumonia, and renal complications are seconda-
ry to hypercalcemia, hypercalciuria, and nephrocalcinosis.
The mortality rate is around 50% [4,6]. Childhood hypo-
Figure. Images of Case 1 with infantile
hypophosphatasia. (A) Roentgenograms
show poor mineralization of the long
bones. (B) Hypomineralization is most
noticeable in the proximal humerus.
(C) Cranial computed tomography scan
shows decreased mineralization of the
skull. (D) Renal ultrasonography
reveals multiple hyperechogenic lesions
over bilateral medulla, consistent with
nephrocalcinosis.
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phosphatasia often presents with premature loss of de-
ciduous teeth and may be associated with rachitic skeletal
defects that occasionally show spontaneous improvement
[6]. Adult hypophosphatasia is the least severe form, with
a history of the premature loss of deciduous teeth followed
by recurrent fractures secondary to osteomalacia. Some
individuals do not develop clinically apparent skeletal dis-
ease [7]. Patients who develop only dental manifestations
are regarded as having odontohypophosphatasia. An ex-
tremely rare variant, pseudohypophosphatasia, resembles
infantile hypophosphatasia except that serum ALP activ-
ity is normal. Case 1 in this report is compatible with the
diagnosis of infantile hypophosphatasia. The patient in
Case 2 was healthy until she suffered two fractures in
adulthood, which is compatible with the clinical course of
adult hypophosphatasia.
It has been estimated that severe forms of hypophos-
phatasia occur in approximately 1/100,000 live births [4].
The milder childhood and adult forms are probably some-
what more common. Less affected hypophosphatasia
patients may show only low levels of ALP in the blood and
never suffer bone problems [4]. Thus, the prevalence of
mild hypophosphatasia may be underestimated. A routine
test for ALP should be used in patients with repeated
fractures or premature exfoliation of deciduous teeth to de-
tect mild forms of hypophosphatasia. Hypophosphatasia
can be diagnosed with confidence in individuals with typi-
cal clinical histories, physical findings, and radiologic
changes in whom serum ALP activity is clearly and con-
sistently subnormal. Although hypercalcemia is relative-
ly common in perinatal and infantile hypophosphatasia,
it is uncommon in childhood and adult forms [8].
The primary pathophysiologic consequence in patients
with hypophosphatasia is reduced TNSALP activity leading
to the accumulation of its endogenous substrates, pyrophos-
phate, pyridoxal-5’-phosphate, and phosphoethanolamine,
and to defective mineralization of skeletal osteoid [9]. The
clinical severity of hypophosphatasia is related to the sites
of mutation in the TNSALP gene. Molecular studies have
shown at least 65 distinctive deactivating TNSALP defects
among hypophosphatasia patients worldwide [10]. Peri-
natal and infantile hypophosphatasias are transmitted as
autosomal recessive traits and can be attributed to homozy-
gous or compound heterozygous mutations in the TNSALP
gene. Subjects with childhood or adult hypophosphatasia
can also be compound heterozygotes for TNSALP muta-
tions. However, it seems possible that mild disease is trans-
mitted as an autosomal dominant trait [4].
There is no established medical regimen for hypophos-
phatasia, although several therapies have been studied
[10–14]. Enzyme replacement therapy by infusion of serum
from patients with high ALP activity has limited benefit
[13]. Bone marrow transplantation may be effective but
requires further evaluation [14]. The administration of vita-
min D or its metabolites is inadvisable because, even in
small doses, these patients develop hypercalcemia easily.
Therapeutic trials are made difficult by the variable clinical
and radiologic course.
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